The incidence of pregnancy hypertension in India, Pakistan, Mozambique, and Nigeria: A prospective population-level analysis
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Most pregnancy hypertension estimates in less-developed countries are from cross-sectional hospital surveys and are considered overestimates. We estimated population-based rates by standardised methods in 27 intervention clusters of the Community-Level Interventions for Pre-eclampsia (CLIP) cluster randomised trials. METHODS AND FINDINGS: CLIP-eligible pregnant women identified in their homes or local primary health centres (2013-2017). Included here are women who had delivered by trial end and received a visit from a community health worker trained to provide supplementary hypertension-oriented care, including standardised blood pressure (BP) measurement. Hypertension (BP ≥ 140/90 mm Hg) was defined as chronic (first detected at <20 weeks gestation) or gestational (≥20 weeks); pre-eclampsia was gestational hypertension plus proteinuria or a pre-eclampsia-defining complication. A multi-level regression model compared hypertension rates and types between countries (p < 0.05 considered significant). In 28,420 pregnancies studied, women were usually young (median age 23-28 years), parous (53.7%-77.3%), with singletons (≥97.5%), and enrolled at a median gestational age of 10.4 (India) to 25.9 weeks (Mozambique). Basic education varied (22.8% in Pakistan to 57.9% in India). Pregnancy hypertension incidence was lower in Pakistan (9.3%) than India (10.3%), Mozambique (10.9%), or Nigeria (10.2%) (p = 0.001). Most hypertension was diastolic only (46.4% in India, 72.7% in Pakistan, 61.3% in Mozambique, and 63.3% in Nigeria). At first presentation with elevated BP, gestational hypertension was most common diagnosis (particularly in Mozambique [8.4%] versus India [6.9%], Pakistan [6.5%], and Nigeria [7.1%]; p < 0.001), followed by pre-eclampsia (India [3.8%], Nigeria [3.0%], Pakistan [2.4%], and Mozambique [2.3%]; p < 0.001) and chronic hypertension (especially in Mozambique [2.5%] and Nigeria [2.8%], compared with India [1.2%] and Pakistan [1.5%]; p < 0.001). Inclusion of additional diagnoses of hypertension and related complications, from household surveys or facility record review (unavailable in Nigeria), revealed higher hypertension incidence: 14.0% in India, 11.6% in Pakistan, and 16.8% in Mozambique; eclampsia was rare (<0.5%). CONCLUSIONS: Pregnancy hypertension is common in less-developed settings. Most women in this study presented with gestational hypertension amenable to surveillance and timed delivery to improve outcomes. TRIAL REGISTRATION: This study is a secondary analysis of a clinical trial - ClinicalTrials.gov registration number NCT01911494.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kassebaum, N. J., Bertozzi-Villa, A., Coggeshall, M. S., Shackelford, K. A., Steiner, C., Heuton, K. R., Gonzalez-Medina, D., Barber, R., Huynh, C., Dicker, D., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60696-6 · Cited by 1,644
Self-citationGlobal and regional estimates of preeclampsia and eclampsia: a systematic review
Abalos, E., Cuesta, C., Grosso, A. L., Chou, D., & Say, L. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.05.005 · Cited by 1,574 · cited 1×
“55% [Africa]) [12,13]; gestational hypertension was excluded from the WHO multicountry survey estimates.”
BackgroundLess-Tight versus Tight Control of Hypertension in Pregnancy
Magee, L. A., von Dadelszen, P., Rey, E., Ross, S., Asztalos, E., Murphy, K. E., Menzies, J., Sanchez, J., Singer, J., Gafni, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1404595 · Cited by 672
Self-citationAbalos, E., Cuesta, C., Carroli, G., Qureshi, Z., Widmer, M., Vogel, J., Souza, J., & on behalf of the WHO Multicountry Survey on Maternal and Newborn Health Research Network (2014) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12629 · Cited by 528
Diversity and divergence: the dynamic burden of poor maternal health
Graham, W., Woodd, S., Byass, P., Filippi, V., Gon, G., Virgo, S., Chou, D., Hounton, S., Lozano, R., Pattinson, R., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31533-1 · Cited by 309 · cited 1×
“The SDGs aim to maintain the momentum of the Millennium Development Goals, which catalysed a global reduction in maternal deaths from approximately 390,000 in 1990 to 275,000 in 2015 [1,2].”
BackgroundGillon, T. E. R., Pels, A., von Dadelszen, P., MacDonell, K., & Magee, L. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113715 · Cited by 210
Self-citationGoudar, S. S., Carlo, W. A., McClure, E. M., Pasha, O., Patel, A., Esamai, F., Chomba, E., Garces, A., Althabe, F., Kodkany, B., et al. (2012) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2012.04.022 · Cited by 144 · cited 1×
“Surveillance occurred quarterly in Pakistan, 6-monthly in Mozambique, and prospectively in near real time via the Global Network for Women’s and Children’s Health Research’s Maternal Newborn Health Registry in India [26].”
MethodSelf-citationUsability and Feasibility of PIERS on the Move: An mHealth App for Pre-Eclampsia Triage
Lim, J., Cloete, G., Dunsmuir, D. T., Payne, B. A., Scheffer, C., von Dadelszen, P., Dumont, G. A., & Ansermino, J. M. (2015) · JMIR mHealth and uHealth · doi:10.2196/mhealth.3942 · Cited by 73 · cited 1×
“Usability and feasibility testing supported experimental implementation into clinical care [21].”
BackgroundSelf-citationNathan, H. L., de Greeff, A., Hezelgrave, N. L., Chappell, L. C., & Shennan, A. H. (2015) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000086 · Cited by 66 · cited 4×
“To our knowledge, this is the first study of pregnancy hypertension incidence and type in less-developed countries that is both population-based in terms of participants and standardised in terms of BP measurement, by positioning and use of a pregnancy-validated BP device [23].”
MethodInfluentialSelf-citation
Cited by
Lai, J., Syngelaki, A., Nicolaides, K. H., von Dadelszen, P., & Magee, L. A. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.11.004 · Cited by 89
Self-citationvon Dadelszen, P., Bhutta, Z. A., Sharma, S., Bone, J., Singer, J., Wong, H., Bellad, M. B., Goudar, S. S., Lee, T., Li, J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31128-4 · Cited by 49
Self-citationBone, J. N., Khowaja, A. R., Vidler, M., Payne, B. A., Bellad, M. B., Goudar, S. S., Mallapur, A. A., Munguambe, K., Qureshi, R. N., Sacoor, C., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2020-004123 · Cited by 14
Self-citation
Metadata
- Authors
- Magee, L. A., Sharma, S., Nathan, H. L., Adetoro, O. O., Bellad, M. B., Goudar, S., Macuacua, S. E., Mallapur, A., Qureshi, R., Sevene, E., Sotunsa, J., Valá, A., Lee, T., Payne, B. A., Vidler, M., Shennan, A. H., Bhutta, Z. A., von Dadelszen, P., & the CLIP Study Group
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-04-12
- Volume
- 16
- Issue
- 4
- Pages
- e1002783
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2936503180
- Cited by
- 135
- References
- 9
- FWCI
- 18.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.